Perimeter Medical Imaging AI Announces C$13.5M Private Placement for Cancer Detection Technology

Funding Initiative Announced

Perimeter Medical Imaging AI, a company specializing in advanced medical imaging technology, has revealed plans to raise approximately C$13.5 million through a non-brokered private placement 1

1

. This strategic move aims to bolster the company's financial position and accelerate the development and commercialization of its innovative cancer detection technology.

Details of the Private Placement

The private placement will consist of units priced at C$1.40 each. Each unit will comprise one common share of the company and one-half of a common share purchase warrant 2

2

. The full warrants will be exercisable at C$1.90 per share for a period of 24 months following the closing of the offering, subject to certain conditions.

Use of Proceeds

Perimeter Medical Imaging AI intends to utilize the net proceeds from this private placement for several key purposes:

1. Advancing the development of its artificial intelligence technology
2. Supporting ongoing clinical studies
3. Expanding its commercial initiatives
4. Bolstering working capital and general corporate purposes 1

   1

Market Impact and Investor Interest

The announcement of this private placement has drawn attention from investors and industry observers. The company's focus on AI-powered cancer detection technology positions it at the forefront of medical imaging innovation, potentially addressing critical needs in cancer diagnosis and treatment.

Regulatory Considerations

It's important to note that the private placement is subject to regulatory approvals, including that of the TSX Venture Exchange 2

2

. The company has stated that all securities issued through this offering will be subject to a statutory hold period of four months and one day from the date of issuance.

Company Background

Perimeter Medical Imaging AI specializes in developing advanced in-procedural medical imaging tools aimed at reducing cancer surgery costs and improving patient outcomes. Their flagship product, the S-Series OCT system, provides real-time, cross-sectional visualization of excised tissues at the cellular level, potentially revolutionizing cancer surgery procedures 1

1

2

2

.

Future Outlook

This funding initiative underscores Perimeter Medical Imaging AI's commitment to advancing its technology and expanding its market presence. The success of this private placement could significantly impact the company's ability to accelerate its research and development efforts, potentially bringing innovative cancer detection solutions to market faster.